Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Reset all filters
01 4AMMONIUM LACTATE
02 1CAPITAL AND CODEINE
03 8CLOBAZAM
04 1E.E.S.
05 1E.E.S. 400
06 2EMFLAZA
07 1ERYPED
08 2EURAX
09 1FLOLIPID
10 1FURADANTIN
11 2GRISEOFULVIN
12 1KIONEX
13 2LAC-HYDRIN
14 1LIKMEZ
15 1NAPROSYN
16 1NAPROXEN
17 1NITROFURANTOIN
18 3NYSTATIN
19 3PHENYTOIN
20 1PRAVASTATIN SODIUM
21 1SELSUN
22 2SODIUM POLYSTYRENE SULFONATE
23 1TIOCONAZOLE
24 1TRI-LUMA
Reset all filters
01 16927
02 17936
03 19112
04 19175
05 118965
06 119155
07 120508
08 121112
09 140028
10 140342
11 140521
12 250207
13 161905
14 162512
15 162876
16 165200
17 165438
18 174190
19 175570
20 175774
21 175883
22 175915
23 176216
24 176939
25 186024
26 189049
27 189892
28 190590
29 1201355
30 1203621
31 1206679
32 1208684
33 1208685
34 1208819
35 1209715
36 1210039
37 1210546
38 1210569
39 1210746
40 1211259
41 1213110
42 1216755
Reset all filters
01 41No
02 2Yes
Drug : NITROFURANTOIN
Dosage Form : SUSPENSION; ORAL
Application Number : 201355
Country : US
Patented : No
Drug : NAPROSYN
Dosage Form : SUSPENSION; ORAL
Application Number : 18965
Country : US
Patented : No

Drug : CLOBAZAM
Dosage Form : SUSPENSION; ORAL
Application Number : 208819
Country : US
Patented : No



Drug : EMFLAZA
Dosage Form : SUSPENSION; ORAL
Application Number : 208685
Country : US
Patented : No


Drug : CLOBAZAM
Dosage Form : SUSPENSION; ORAL
Application Number : 211259
Country : US
Patented : No

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Drug : NYSTATIN
Dosage Form : SUSPENSION; ORAL
Application Number : 62512
Country : US
Patented : No

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF